Aytu Biopharma (AYTU) Inventory Average (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Inventory Average data on file, last reported at $8.1 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $8.1 million, down 27.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (down 27.22% YoY), and the FY2025 annual result was $11.8 million, down 2.32% from the prior year.
• Inventory Average retreated to $8.1 million in Q1 2026 per AYTU's latest filing, from $9.4 million in the prior quarter.
• Over five years, Inventory Average peaked at $15.2 million in Q1 2022 and troughed at $8.1 million in Q1 2026.
• A 5-year average of $12.0 million and a median of $12.4 million in 2022 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2023: Inventory Average declined 27.36% in 2022, then rose 5.23% in 2023.
• A 5-year view of Inventory Average shows it stood at $12.9 million in 2022, then climbed by 0.57% to $13.0 million in 2023, then decreased by 12.1% to $11.4 million in 2024, then slipped by 17.82% to $9.4 million in 2025, then decreased by 14.08% to $8.1 million in 2026.
• Business Quant data shows AYTU's Inventory Average at $8.1 million in Q1 2026, $9.4 million in Q4 2025, and $10.8 million in Q3 2025.